URGN CIK: 1668243

UroGen Pharma Ltd.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
42.9
FY22:
56.7
FY23:
73.4
FY24:
81.5
FY25:
97.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−92.3
FY22:
−79.0
FY23:
−65.5
FY24:
−96.8
FY25:
−125
(positive)
Change from FY21 to FY25
millions USD
FY21:
−90.3
FY22:
−76.2
FY23:
−60.4
FY24:
−110
FY25:
−136
(positive)
Change from FY21 to FY25
millions USD
FY21:
−109
FY22:
−108
FY23:
−98.3
FY24:
−124
FY25:
−153
(positive)
Change from FY21 to FY25
millions USD
FY21:
−111
FY22:
−110
FY23:
−102
FY24:
−127
FY25:
−153

All amounts in millions USD Data sources:SEC EDGARTwelve Data